ZHAO Wen-xia1, LIU Quan-zhong1, XIA Jin-yu2, et al. Clinical Trial of Chinese Medicine for the Treatment of Nonalcoholic Steatohepatitis[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(23): 246-249.
ZHAO Wen-xia1, LIU Quan-zhong1, XIA Jin-yu2, et al. Clinical Trial of Chinese Medicine for the Treatment of Nonalcoholic Steatohepatitis[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(23): 246-249. DOI: 10.13422/j.cnki.syfjx.2011.23.005.
Clinical Trial of Chinese Medicine for the Treatment of Nonalcoholic Steatohepatitis
Objective:To investigate the effects of the Chinese medicine on non-alcoholic steatohepatitis(NASH).Method: Serum alanine aminotransferase(ALT)
liver to spleen ratio triglyceride(TG)
body mass index(BMI) and symptom signs of impact in patients were used for effecacy evaluation.In all
202 patients with NASH were collected from four sub-centers and randomly divided into treatment group(101cases) and control group(101 cases).The patients of treatment group were treated for 3 months with a daily traditional Chinese medicine
and the patients of control group were treated for 3 months with polyene phosphatidylcholine capsules(Essentiale)
1 368 mg·d-1.Each patient was advised regular aerobic exercise and dietary modification.Result: The treatment group was significantly better than control group on improved serum ALT levels
liver to spleen ratios
TG
body mass index BMI and symptoms(P<0.05).Conclusion: The Chinese medicine for the treatment of NASH was better than Essentiale for improveing ALT levels
liver to spleen ratios
TG
BMI and symptoms.It can be promoted as a clinical treatment.
Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1
Effects of Zizhu Ointment Combined with Tendon Clearance on Serum Levels of NLRP3, IL-1β, and IL-18, in Treatment of Non-ischemic Diabetic Foot Ulcers
Clinical Effect of Tinglu Yixin Prescription on Heart Failure with Preserved Ejection Fraction with Diabetes: From Taste-based Compatibility and Descending Adverse Qi with Bitter and Pungent Medicinals
Modified Weijingtang Regulates Pyroptosis of Macrophages via Caspase-1/GSDMD Pathway
Related Author
ZHAO Wen-xia
LIU Quan-zhong
XIA Jin-yu
CHANG Zhan-jie
SHENG Guo-guang
JI Ai-ying
ZHOU Yao-yong
LI Ri-xiang
Related Institution
The First Clinical Medical College, Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Nanjing Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Nanjing University of Chinese Medicine